Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Daiichi Sankyo, Inc.; Eisai Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.
Community Practice Connections™: 5th Annual School of Nursing Oncology™
Release Date: October 29, 2021
Expiration Date: October 29, 2022
Activity Overview
This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the 5th Annual School of Nursing OncologyTM, held in August 2021. This unique, engaging, multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with melanoma, renal cell carcinoma, or non-small cell lung cancer, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Acknowledgement of Commercial Support
This activity is supported by educational grants from Daiichi Sankyo, Inc.; Eisai Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate recently reported clinical trial data that are relevant for treatment of solid and hematologic malignancies
- Explain practice changing trial evidence relevant to the contemporary management of solid and hematologic malignancies
- Identify biomarkers and relevant assays, including genetic and genomic testing, that have predictive or prognostic value to individualize decision-making for patients with cancer
- Develop strategies to monitor for and mitigate adverse events associated with immunotherapies, targeted therapies, and other current or emerging agents in oncology
- Apply patient counseling strategies to clinical scenarios to improve treatment adherence along the disease continuum and including survivorship
- Assess evidence-based supportive care strategies for cancer- and treatment-related symptom management
- Integrate methods for multidisciplinary care coordination and patient counseling strategies to optimize shared decision-making in the care of patients with cancer, including decisions concerning clinical trial participation
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities
Faculty
Oncology Nurse Practitioner
UCLA Melanoma Program
University of California, Los Angeles
Los Angeles, CA
Disclosures: Consultant: Merck & Co; Speakers’ Bureau: Merck & Co., Novartis Pharmaceuticals Corporation, Sanofi Genzyme.
Thoracic Oncology Nurse Practitioner
Abramson Cancer Center
Hospital of the University of Pennsylvania
Philadelphia, PA
Disclosures: Speakers’ Bureau: Takeda Pharmaceutical Company, AstraZeneca, Merck & Co.
Renal Cancer Research Coordinator
Taussig Cancer Center
Cleveland Clinic
Cleveland, OH
Disclosures: Consultant: Eisai Inc.; Speakers’ Bureau: Bristol Myers Squibb, Merck & Co., Pfizer.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.
